Modified Immune Cells (AFM13-NK) and A Monoclonal Antibody (AFM13) in Treating Patients With Recurrent or Refractory CD30 Positive Hodgkin or Non-Hodgkin Lymphomas
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Universität des Saarlandes
Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine
Ohio State University Comprehensive Cancer Center
University of Nebraska
City of Hope Medical Center
Wake Forest University Health Sciences
University of Nebraska
University of Nebraska
City of Hope Medical Center
University of Nebraska
The Lymphoma Academic Research Organisation
University of Nebraska
University of Nebraska
Massachusetts General Hospital
University of Milano Bicocca
Columbia University
Goethe University
Gustave Roussy, Cancer Campus, Grand Paris
Mayo Clinic
Memorial Sloan Kettering Cancer Center
Samsung Medical Center
Northwestern University
Roswell Park Cancer Institute
Universität des Saarlandes
Universität des Saarlandes
Roswell Park Cancer Institute
German High-Grade Non-Hodgkin's Lymphoma Study Group
Masonic Cancer Center, University of Minnesota
Children's Hospital Medical Center, Cincinnati
Mayo Clinic
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Case Comprehensive Cancer Center
Columbia University
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
University of Wisconsin, Madison
Mayo Clinic
Roswell Park Cancer Institute
Fred Hutchinson Cancer Center
Mayo Clinic
Roswell Park Cancer Institute